Related Experiment Videos
Pterygium surgery with mitomycin-C: ten-year results
1St. Croix Vision Center, Christiansted, Virgin Islands 00823, USA.
Ophthalmic Surgery and Lasers
|July 28, 2001
Summary
A pterygium surgery review found the merest sclera conjunctival flap technique with mitomycin-C had a low recurrence rate of 0.35%. This safe method resulted in no vision-threatening complications and mild, treatable side effects.
Area of Science:
- Ophthalmology
- Surgical Techniques
Background:
- Pterygium is a common eye condition that can affect vision.
- Surgical intervention is often necessary for pterygium removal.
- Recurrence after pterygium surgery remains a clinical challenge.
Purpose of the Study:
- To evaluate the efficacy and safety of the merest sclera conjunctival flap technique combined with mitomycin-C for pterygium treatment.
- To assess the recurrence rates and complications associated with this surgical approach.
Main Methods:
- A retrospective review of 870 primary and recurrent pterygium cases.
- Surgical technique involved the merest sclera conjunctival flap.
- A single subconjunctival application of mitomycin-C (0.1 cc of 0.4 mg/mL) was administered.
Main Results:
- A low recurrence rate of 3 cases (0.35%) was observed.
- No vision-threatening complications were reported.
- Adverse effects were mild and resolved with topical treatment.
Conclusions:
- The merest sclera conjunctival flap technique with mitomycin-C is a highly effective and safe surgical option for pterygium.
- This method significantly reduces the risk of recurrence.
- The procedure is well-tolerated with minimal adverse effects.